VectivBio (VECT) Competitors

$16.85 0.00 (0.00%)

As of 05/1/2026

VECT vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying VectivBio stock or one of its competitors? The main competitors of VectivBio include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does VectivBio compare to Ainos?

VectivBio (NASDAQ:VECT) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.

: Company Net Margins Return on Equity Return on Assets
VectivBio N/A N/A N/A
Ainos N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VectivBio N/A N/A N/A N/A N/A
Ainos $124.16K N/A N/A N/A N/A
: In the previous week, VectivBio's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.
Company Overall Sentiment
VectivBio Neutral
Ainos Neutral

Company	Net Margins	Return on Equity	Return on Assets
VectivBio	N/A	N/A	N/A
Ainos	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VectivBio	N/A	N/A	N/A	N/A	N/A
Ainos	$124.16K	N/A	N/A	N/A	N/A

Company	Overall Sentiment
VectivBio	Neutral
Ainos	Neutral

Summary

Ainos beats VectivBio on 1 of the 1 factors compared between the two stocks.

How does VectivBio compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and VectivBio (NASDAQ:VECT) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

: Company Net Margins Return on Equity Return on Assets
Alvotech N/A N/A N/A
VectivBio N/A N/A N/A
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alvotech $586.32M N/A N/A N/A N/A
VectivBio N/A N/A N/A N/A N/A
: In the previous week, Alvotech's average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.
Company Overall Sentiment
Alvotech Neutral
VectivBio Neutral

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
VectivBio	N/A	N/A	N/A

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$586.32M	N/A	N/A	N/A	N/A
VectivBio	N/A	N/A	N/A	N/A	N/A

Company	Overall Sentiment
Alvotech	Neutral
VectivBio	Neutral

Summary

Alvotech beats VectivBio on 1 of the 1 factors compared between the two stocks.

How does VectivBio compare to Aravive?

VectivBio (NASDAQ:VECT) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, earnings, analyst recommendations, valuation, media sentiment, profitability and risk.

: 35.8% of Aravive shares are held by institutional investors. 9.7% of VectivBio shares are held by insiders. Comparatively, 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VectivBio N/A N/A N/A N/A N/A
Aravive N/A N/A N/A -$0.90 N/A
: Company Net Margins Return on Equity Return on Assets
VectivBio N/A N/A N/A
Aravive N/A N/A N/A
: In the previous week, VectivBio's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.
Company Overall Sentiment
VectivBio Neutral
Aravive Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VectivBio	N/A	N/A	N/A	N/A	N/A
Aravive	N/A	N/A	N/A	-$0.90	N/A

Company	Net Margins	Return on Equity	Return on Assets
VectivBio	N/A	N/A	N/A
Aravive	N/A	N/A	N/A

Company	Overall Sentiment
VectivBio	Neutral
Aravive	Neutral

Summary

Aravive beats VectivBio on 2 of the 2 factors compared between the two stocks.

How does VectivBio compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and VectivBio (NASDAQ:VECT) are both pharmaceutical products companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

: In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.
Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
VectivBio Neutral
: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II N/A N/A N/A N/A N/A
VectivBio N/A N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. II N/A N/A N/A
VectivBio N/A N/A N/A

Company	Overall Sentiment
Atlantic Coastal Acquisition Corp. II	Neutral
VectivBio	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A	N/A	N/A
VectivBio	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Atlantic Coastal Acquisition Corp. II	N/A	N/A	N/A
VectivBio	N/A	N/A	N/A

Summary

Atlantic Coastal Acquisition Corp. II and VectivBio tied by winning 0 of the 0 factors compared between the two stocks.

How does VectivBio compare to Avidity Biosciences?

VectivBio (NASDAQ:VECT) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

: Avidity Biosciences has a consensus price target of $69.42, suggesting a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than VectivBio.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
VectivBio
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)

12 Hold rating(s)

5 Buy rating(s)

1 Strong Buy rating(s)
2.32
: VectivBio has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. VectivBio's return on equity of 0.00% beat Avidity Biosciences' return on equity.
Company Net Margins Return on Equity Return on Assets
VectivBio N/A N/A N/A
Avidity Biosciences -3,650.39% -44.92% -39.57%
: In the previous week, Avidity Biosciences had 1 more articles in the media than VectivBio. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for VectivBio. VectivBio's average media sentiment score of 0.00 equaled Avidity Biosciences'average media sentiment score.
Company Overall Sentiment
VectivBio Neutral
Avidity Biosciences Neutral
: VectivBio has higher earnings, but lower revenue than Avidity Biosciences.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
VectivBio N/A N/A N/A N/A N/A
Avidity Biosciences $18.62M N/A -$322.30M N/A N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VectivBio	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Avidity Biosciences	1 Sell rating(s)	12 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.32

Company	Net Margins	Return on Equity	Return on Assets
VectivBio	N/A	N/A	N/A
Avidity Biosciences	-3,650.39%	-44.92%	-39.57%

Company	Overall Sentiment
VectivBio	Neutral
Avidity Biosciences	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VectivBio	N/A	N/A	N/A	N/A	N/A
Avidity Biosciences	$18.62M	N/A	-$322.30M	N/A	N/A

Summary

Avidity Biosciences beats VectivBio on 6 of the 9 factors compared between the two stocks.

Get VectivBio News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VECT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

VECT vs. The Competition

Export

Metric	VectivBio	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$3.40B	$6.25B	$11.77B
Dividend Yield	N/A	2.23%	2.74%	5.26%
P/E Ratio	N/A	38.57	29.25	27.07
Price / Sales	N/A	280.02	504.68	73.43
Price / Cash	N/A	125.06	43.30	53.90
Price / Book	N/A	7.05	9.67	6.69
Net Income	N/A	$23.62M	$3.55B	$332.64M
7 Day Performance	N/A	3.67%	1.70%	2.01%
1 Month Performance	N/A	7.17%	5.62%	9.19%
1 Year Performance	N/A	67.04%	34.42%	39.59%

VectivBio Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
VECT VectivBio	N/A	$16.85 flat	N/A	N/A	$0.00	N/A	N/A	30	High Trading Volume
AIMDW Ainos	N/A	$0.11 flat	N/A	N/A	$0.00	$124.16K	N/A	40	Positive News
ALVOW Alvotech	N/A	$0.21 -18.2%	N/A	N/A	$0.00	$586.32M	N/A	4	Upcoming Earnings Gap Down High Trading Volume
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
ACABW Atlantic Coastal Acquisition Corp. II	N/A	$0.00 flat	N/A	N/A	$0.00	N/A	N/A	15

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:VECT) was last updated on 5/5/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

VectivBio (VECT) Competitors